As Auvelity is recently approved, Axsome now has two solid drugs that are likely to generate significant market traction. Read what this means for AXSM stock.
Axsome Therapeutics to Present at the 5th Annual Evercore ISI HealthCONx Conference streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
07.11.2022 - Sunosi third quarter U.S. net sales of $16.8 million Auvelity launched and available in U.S. pharmacies SHARP study results announced demonstrating statistically significant improvement in cognitive function with Sunosi versus placebo ADVANCE-2 .